These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 7067171

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma middle molecules in asymptomatic and "sick" uremic patients.
    Asaba H, Bergström J, Fürst P, Johnson C, Yahiel V.
    Artif Organs; 1981; 4 Suppl():137-42. PubMed ID: 7295080
    [Abstract] [Full Text] [Related]

  • 3. Clinical implications of uremic middle molecules in regular hemodialysis patients.
    Asaba H, Alvestrand A, Fürst P, Bergström J.
    Clin Nephrol; 1983 Apr; 19(4):179-87. PubMed ID: 6851254
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H, Fürst P, Oulés R, Yahiel V, Zimmerman L, Bergström J.
    Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
    [Abstract] [Full Text] [Related]

  • 6. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R, Emond C, Claret G, Branger B, Mion H, Mion C.
    Artif Organs; 1981 May; 4 Suppl():177-83. PubMed ID: 7295089
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Renal handling of middle molecules in uremic patients and in the isolated rat kidney.
    Lustenberger N, Schindhelm K, Nordmeyer C, Schurek HJ, Stolte H.
    Artif Organs; 1981 May; 4 Suppl():110-4. PubMed ID: 7295076
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Middle molecular weight substances and uremic polyneuropathy.
    Dukanović L, Petrović J, Potić J.
    Acta Med Iugosl; 1990 May; 44(2):117-28. PubMed ID: 2162129
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].
    Kovalishin IaF, Nikolaev VG, Baran EIa, Dudar' IA, Iushko LA.
    Vopr Med Khim; 1988 May; 34(6):23-6. PubMed ID: 3238937
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Methodology for identification of serum middle molecules.
    Buzio C, Montagna G, Calderini C, Manari A, Migone L.
    Artif Organs; 1981 May; 4 Suppl():22-7. PubMed ID: 7295090
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
    Sarnatskaya VV, Yushko LA, Sakhno LA, Nikolaev VG, Nikolaev AV, Grinenko DV, Mikhalovsky SV.
    Artif Cells Blood Substit Immobil Biotechnol; 2007 May; 35(3):287-308. PubMed ID: 17573628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.